Inspire(US:INSP) Newsfileยท2025-11-10 22:49Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Inspire Medical Systems, Inc. due to allegations of misleading statements regarding the launch and demand for its Inspire V device, which has led to significant financial losses for investors [2][5][8]. Group 1: Legal Investigation - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in Inspire Medical to contact them for legal options [1]. - There is a deadline of January 5, 2026, for investors to seek the role of lead plaintiff in a federal securities class action against Inspire Medical [2]. Group 2: Allegations Against Inspire Medical - The complaint alleges that Inspire Medical and its executives violated federal securities laws by making false statements about the market demand for the Inspire V device and the company's readiness for its launch [5]. - Inspire Medical announced on August 4, 2025, that the launch of the Inspire V device faced significant delays due to incomplete training and onboarding at treatment centers, as well as billing and reimbursement challenges [6]. Group 3: Financial Impact - Following the announcement of setbacks, Inspire Medical reported weak demand and excess inventory for the Inspire V device, leading to a more than 80% cut in its 2025 earnings guidance [8]. - The stock price of Inspire Medical fell over 32% in one day, from $129.95 per share on August 4, 2025, to $87.91 per share on August 5, 2025, resulting in a loss of approximately $1.2 billion in market capitalization [8].